---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-200017"
form_type: "8-K"
ticker: "RVMD"
cik: "0001628171"
company_name: "Revolution Medicines, Inc."
filed_at: "2022-07-22T23:59:59+00:00"
generated_at: "2026-06-24T09:34:21.490016+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Revolution Medicines raises $248M net in public offering of 13.225M shares at $20/share

## Summary
- Sold 13.225M shares (including full exercise of underwriters' option) at $20.00 per share public price.
- Net proceeds of approximately $248.0M after underwriting discounts and offering expenses.
- Underwriters include J.P. Morgan, Cowen, Guggenheim; lock-up period of 60 days for directors and officers.
- Offering closed on July 22, 2022.

## SEC filing metadata
- accession: 0001193125-22-200017
- form_type: 8-K
- ticker: RVMD
- cik: 0001628171
- company_name: Revolution Medicines, Inc.
- filed_at: 2022-07-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628171/000119312522200017/0001193125-22-200017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628171/000119312522200017/d61456d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-200017
- JSON: https://secwatch.observer/filing/0001193125-22-200017.json
- Plain text: https://secwatch.observer/filing/0001193125-22-200017.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.